Question 1

What specific benefits might ITI-007 provide compared to my current treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Clinical Trial Evaluating ITI-007 as an Adjunctive Therapy to Lithium or Valproate for the Treatment of Bipolar Depression clinical trial (NCT02600507). Contact the study team or your healthcare provider for specific answers.

Question 2

What are the potential side effects of ITI-007?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Clinical Trial Evaluating ITI-007 as an Adjunctive Therapy to Lithium or Valproate for the Treatment of Bipolar Depression clinical trial (NCT02600507). Contact the study team or your healthcare provider for specific answers.

Question 3

How will my progress be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Clinical Trial Evaluating ITI-007 as an Adjunctive Therapy to Lithium or Valproate for the Treatment of Bipolar Depression clinical trial (NCT02600507). Contact the study team or your healthcare provider for specific answers.

Question 4

What happens if I experience worsening symptoms while participating?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Clinical Trial Evaluating ITI-007 as an Adjunctive Therapy to Lithium or Valproate for the Treatment of Bipolar Depression clinical trial (NCT02600507). Contact the study team or your healthcare provider for specific answers.

Question 5

Are there any additional visits or tests required if I join this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Clinical Trial Evaluating ITI-007 as an Adjunctive Therapy to Lithium or Valproate for the Treatment of Bipolar Depression clinical trial (NCT02600507). Contact the study team or your healthcare provider for specific answers.

Question 6

How does this trial compare to other treatment options available for my condition?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Clinical Trial Evaluating ITI-007 as an Adjunctive Therapy to Lithium or Valproate for the Treatment of Bipolar Depression clinical trial (NCT02600507). Contact the study team or your healthcare provider for specific answers.

What this study is about